Quest Diagnostics | DGX - Ebitda

Stock Price
189.17
Daily Change
4.00 2.16%
Monthly
9.04%
Yearly
14.74%
Q1 Forecast
181.27

Quest Diagnostics reported $561M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Acadia Healthcare USD 173.02M 28.82M Sep/2025
Agilent USD 466M 5M Jun/2025
Baxter International USD 462M 137M Jun/2025
Bruker USD 128.1M 27.1M Jun/2025
Cardinal Health USD 986M 319M Sep/2025
Centene USD 117M 111M Sep/2025
Charles River Laboratories USD 282.89M 64.81M Sep/2025
Cigna USD 2.86B 56M Mar/2025
CVS Health USD 4.09B 392M Sep/2025
Danaher USD 2.13B 252M Dec/2025
DaVita Healthcare Partners USD 772.7M 89.45M Dec/2025
Elevance Health USD 2.19B 1.01B Sep/2025
Encompass Health USD 300.1M 18.5M Sep/2025
HCA USD 4.11B 244M Dec/2025
Henry Schein USD 295M 39M Sep/2025
Humana USD 824M 546M Sep/2025
Illumina USD 332M 12M Sep/2025
IQVIA Holdings USD 949M 39M Sep/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
McKesson USD 1.68B 418M Sep/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Molina Healthcare USD 185M 265M Sep/2025
Owens Minor USD 96.6M 12.17M Jun/2025
Quest Diagnostics USD 561M 9M Sep/2025
Revvity USD 248.91M 48.52M Dec/2025
Tenet Healthcare USD 1.1B 22M Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
UnitedHealth USD 1.5B 3.92B Dec/2025
Universal Health Services USD 670.6M 27.72M Sep/2025
Waters USD 295.14M 18.87M Sep/2025
Zoetis USD 1.04B 87M Sep/2025